Considering the influence of ageing on the heterogeneity of prostate cancer as well as clinical prognosis, an ageing-derived gene signature comprised of ARGLU1, EIF2S2, and AP000844.2 was conducted based on WGNCA, random forest, and uni- and multivariate cox regression models. This evidence concerns the gene ARGLU1 and Familial prostate cancer.